A commentary on the anti-sickling effect of the phenothiazine drugs.
D000755:Anemia, Sickle Cell / Q000150:complications / Q000188:drug therapy*; D002648:Child; D003622:Dapsone / Q000494:pharmacology; D004912:Erythrocytes / Q000187:drug effects; D005260:Female; D005954:Glucosephosphate Dehydrogenase / Q000037:antagonists & inhibitors; D005955:Glucosephosphate Dehydrogenase Deficiency / Q000150:complications; D006801:Humans; D008297:Male; D010070:Oxalates / Q000494:pharmacology; D011395:Promazine / Q000494:pharmacology / Q000627:therapeutic use*; D013450:Sulfones / Q000494:pharmacology
D010070:Oxalates; D013450:Sulfones; D003622:Dapsone; D005954:Glucosephosphate Dehydrogenase; D011395:Promazine